Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 12-2010 | 06-2010 | 12-2009 | 06-2009 | |
| Sales | 0 | 0 | 0 | 140 | 0 |
| Gross Profit | N/A | 0 | N/A | 140 | N/A |
| Operating Expenses | 0 | 1,490 | 0 | 2,100 | 0 |
| Operating Income | N/A | -1,490 | N/A | -1,960 | N/A |
| Interest Expense | 0 | 20 | 0 | 180 | 0 |
| Other Income | 0 | 380 | 0 | 440 | 0 |
| Pre-tax Income | 0 | -1,130 | 0 | -1,700 | 0 |
| Net Income Continuous | N/A | -15,538 | N/A | -5,249 | N/A |
| Net Income | $N/A | $-1,130 | $N/A | $-1,700 | $N/A |
| EPS Basic Total Ops | N/A | -53,600.00 | N/A | -24,000.00 | N/A |
| EPS Basic Continuous Ops | N/A | -38,845.00 | N/A | -26,245.00 | N/A |
| EPS Diluted Total Ops | N/A | -53,600.00 | N/A | -24,000.00 | N/A |
| EPS Diluted Continuous Ops | N/A | -38,845.00 | N/A | -26,245.00 | N/A |
| EBITDA(a) | $N/A | $-1,430 | $N/A | $-140 | $N/A |